Skip to main content

Day: May 3, 2021

SERSTECH AB: Serstech publishes memorandum prior to Rights Issue

Serstech hereby announce that the memorandum containing terms and conditions prior to the upcoming rights issue is available on Serstechs website www.serstech.com/rightsissue. Summary of the offeringSubscription period: 7 May – 21 May 2021. Subscription price: 1.95 SEK per share. Volume of issuance: The offer contains at most 12 572 412 shares, corresponding to approx. 24.5 MSEK. Record date:The record date will be the 5th of May 2021. Last day of trading in the share including the right to receive preferential rights will be the 3rd of May 2021. First day of trading in the share without the right to receive preferential rights will be the 4th of May 2021. Preferential rights:Those who, on the record date 5th of May, are registered as share holders in Serstech AB holds preferential rights of signing shares in the rights...

Continue reading

Change in Realkredit Danmark A/S’s Executive Board

To NASDAQ Copenhagen   The Board of Directors Lersø Parkallé 100 DK-2100 København Ø www.rd.dk Telephone +45 7012 5300 3 May 2021   Company Announcement No 39/2021   Change in Realkredit Danmark A/S’s Executive Board   The CEO Carsten Nøddebo Rasmussen has indicated, that he wish to resign his position as CEO of Realkredit Danmark A/S. In that connection Kamilla Hammerich Skytte will be employed at the latest on 1 February 2022 as member of the Executive Board of Realkredit Danmark with a view to replace Carsten Nøddebo Rasmussen as CEO after a short transition period.   Kamilla Hammerich Skytte has been CEO of Nordea Kredit Realkreditaktieselskab since June 2020. Kamilla Hammerich Skytte, age 48, holds a Master Degree in Economics from the University of Copenhagen.     Yours faithfully   The Board of Directors     For...

Continue reading

Pegasus Europe confirms final offering proceeds

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. AMSTERDAM, May 03, 2021 (GLOBE NEWSWIRE) — Pegasus Europe (“Pegasus”), the Special Purpose Acquisition Company focused on opportunities in the European financial services industry, today confirms final offering proceeds of €483,555,410 following the partial exercise of the put option by the stabilisation manager. Citigroup Global Markets Europe AG (“Citigroup”), acting as the stabilisation manager on behalf of the Joint Global Coordinators (as defined in the disclaimer), has today given notice of a partial exercise of the put option granted to it by Pegasus in respect of 6,000,000 Option Units...

Continue reading

Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine

Sandoz to begin enrolling patients with neovascular age-related macular degeneration in MYLIGHT Phase lll confirmatory efficacy and safety study1 Neovascular age-related macular degeneration accounts for 10% of age-related macular degeneration cases, but is responsible for 90% of AMD-related blindness2 With eight marketed biosimilar medicines globally and 15+ molecules in pipeline, Sandoz is investing in future of biosimilars for patients and healthcare systemsHolzkirchen, May 3, 2021 – Sandoz, a Novartis division, today announced progress in the late-stage clinical development program for its proposed biosimilar aflibercept. Sandoz will begin enrolling the first patient in MYLIGHT, a clinical Phase III confirmatory efficacy and safety study, shortly1. Aflibercept is indicated to improve visual acuity in patients with neovascular...

Continue reading

Trifork acquires Swiss IT-firm Vilea to expand market position in Switzerland

Company announcement no. 07 / 2021 Schindellegi, Switzerland – 3 May 2021Trifork Holding AG (Trifork), a next-generation IT and business services provider which strives to be at the forefront of digital innovation, announces today that it has completed the acquisition of Vilea, a Swiss-based IT-firm specializing in designing and delivering tailor-made mobile enterprise applications, in a move aimed at expanding Trifork’s position in Switzerland and central Europe. Vilea has 11 employees in offices in Zürich and Vienna. Combining Trifork’s ecosystem of technological competencies, with Vilea’s talented team and solid reputation in engineering and developing user-centric enterprise apps, the acquisition is a sound starting point for further strengthening the combined position in the Swiss market. “Switzerland is one of the core countries...

Continue reading

Trifork erwirbt Schweizer IT-Firma Vilea zum Ausbau der Marktposition in der Schweiz

Press Release Schindellegi, Schweiz – 3. Mai 2021Die Trifork Holding AG (Trifork), ein Next-Generation-IT- und Business-Services-Anbieter, der bestrebt ist, an der Spitze der digitalen Innovation zu stehen, gibt heute den Abschluss der Akquisition von Vilea bekannt, um damit die Position von Trifork in der Schweiz und in Zentraleuropa auszubauen. Vilea ist ein Schweizer IT-Unternehmen, das sich auf die Entwicklung massgeschneiderter mobiler Softwarelösungen für Unternehmen spezialisiert hat. Vilea hat 11 Mitarbeiter in Büros in Zürich und Wien. Durch die Kombination der technologischen Kompetenzen von Trifork mit dem talentierten Team von Vilea und der soliden Erfahrung in der Konzeption und Entwicklung von benutzerzentrierten Unternehmensanwendungen ist die Partnerschaft ein guter Ausgangspunkt für die weitere Stärkung der gemeinsamen...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.